Sobre Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. was a pharmaceutical company headquartered in South San Francisco, California that developed and marketed cancer treatment medications. It was founded and incorporated with the California Secretary of State in February 1992 by venture capitalist Kevin J. Kinsella and Frank McCormick, Ph.D., FRS, D.Sc. (Hon.), a renowned British-American biochemist. McCormick served as the chief scientific officer until 1996, while Kinsella chaired the company's board of directors. On March 26, 1996, Onyx withdrew its corporate registration with the California Secretary of State and reincorporated in the state of Delaware in advance of successfully taking the company public on the NASDAQ exchange using National Market symbol ONXX on May 9, 1996. In 2009, the company acquired private biotechnology company Proteolix for US$276 million in cash plus additional milestone payments. In January 2012, the company was named "the top biotechnology takeover target in 2012" in an industry survey conducted by the ISI Group. Onyx president and CEO N. Anthony Coles had said that Onyx liked its prospects as an independent company and was focused on bringing new therapies to patients. However, by the end of August 2013, Amgen announced that it was acquiring Onyx in an agreed US$10.4 billion deal.
Source: Wikipedia
SedeCorporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Fundado2013
StatusAtivo
Patentes60 patentes
METHODS OF TREATING MULTIPLE MYELOMA USING BCL-2 INHIBITOREP4558143A4 · 2026
Methods of treating multiple myelomaUS12636340B2 · 2026
Inicie sessão para ver as 60 patentes
Consulte todo o portefólio de patentes, com números de publicação, datas e famílias.
Entrar Criar uma conta com o seu e-mailÉ grátis
Ao continuar, aceita o Contrato de Utilizador, a Política de Privacidade e a Política de Cookies do Heelky.
Avaliações
Ainda não há avaliações. Trabalhou com Onyx Pharmaceuticals, Inc.? Seja o primeiro a compartilhar sua experiência.
Informações legais
| Razão social | Onyx Pharmaceuticals, Inc. |
|---|---|
| LEI | 549300K47GO90N8J4853Ver em GLEIF ↗ |
| Endereço registrado | Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US |
| Status | Ativo |
Fontes: GLEIF · atualizado 16 de outubro de 2026
Contato e links
Localização
Corporation Trust Center, 1209 Orange Street, 19801, Wilmington, US
Esta é a sua empresa?
Reivindique esta página gratuitamente para adicionar seu logotipo, produtos, fotos e vagas, e para responder às avaliações.
Reivindicar esta páginaEntre no Heelky para se conectar, contratar e crescer
Crie uma conta gratuita para enviar mensagens, candidatar-se a vagas e publicar missões.
Cadastre-se — é grátis